Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN) announced that Peter A. Thompson, M.D., FACP, President, Chief Executive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE